Pexidartinib hydrochloride
| CAS No. | 2040295-03-0 | Cat. No. | BCP29551 |
| Name | Pexidartinib hydrochloride | ||
| Synonyms | PLX 3397 HCl;PLX-3397 HCl;Pexidartinib HCl;PLX3397 HCl;PLX-3397 hydrochloride; | ||
| Formula | C20H16Cl2F3N5 | M. Wt | 454.278 |
| Description | Pexidartinib Hydrochloride is the hydrochloride salt form of pexidartinib, a small-molecule receptor tyrosine kinase (RTK) inhibitor of proto-oncogene receptor tyrosine kinase (KIT), colony-stimulating factor-1 receptor (CSF1R) and FMS-like tyrosine kinase 3 (FLT3), with antineoplastic activity. Upon oral administration, pexidartinib targets, binds to and inhibits phosphorylation of KIT, CSF1R and FLT3 harboring an internal tandem duplication (ITD) mutation. This results in the inhibition of tumor cell proliferation. FLT3, CSF1R and FLT3 are overexpressed or mutated in many cancer cell types and play major roles in tumor cell proliferation and metastasis. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | c Kit cFMS | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.